SlideShare a Scribd company logo
Nuova IOL TRIFOCALE:
caratteristiche tecniche
Francesca Pietrolucci
UOC Oftalmologia AUSL/RI
Diffractive Trifocal IOLs
the newest option to compensate presbyopia
• Diffractive trifocal pattern
• No clinically significant deterioration of visual quality
• Different models avoidable
First Generation
• PhysIOL
• FineVision Micro F – Launched in 2010
• FineVision Toric – Launched in 2014
• Carl Zeiss Meditec
• AT LISA tri 839MP – Launched in 2012
• AT LISA tri Toric 939MP – Launched in 2013
Second Generation
• Alcon
• AcrySof PanOptix IOL – Launched in 2015
• AcrySof PanOptix Toric IOL – Launched in 2017
Evolution of Trifocal IOL’s Design
Traditional Trifocal:
• 2 step heights = 2 add powers
• Intermediate focal point of 80 cm to maintain
usable near vision
Quadrifocal Technology:
• 3 step heights = 3 add powers
• Energy evenly distributed among Distance, 120
cm, 60 cm and 40 cm
ENLIGHTEN™ Optical Technology:
• 2 step heights = 2 add powers
• Redirects light from the 1st step height (120 cm)
to Distance
• Light splits three ways: Distance, 60 cm, and 40
cm
Energy
Distan
0th
1/40 1/Focal
2nd distance
Energy
1/120 1/40 1/Focal
3rd
Distance
0th
distance
Energy
1/40 1/Focal
3rd
Dist
0 distance
6 | EMEA 2018 | Jan 2018
In-vitro, bench characterization via MTF
PanOptix IOL vs. ReSTOR +3.0 D IOL Lee et al Clin Ophthalmol. 2016:10 1031–1038
50 lp/mm100 lp/mm
8 | EMEA 2018 | Jan 2018
Multicenter defocus curve evaluation of a novel trifocal presbyopia correcting intraocular lens:
6 months postoperative results. Kohnen T, et al
• Purpose: To determine the binocular defocus curve of the AcrySof IQ PanOptix IOL, at 6 months post-
implantation
• Methods: Prospective, single-arm, non-randomized and multicenter study. A total of 143 subjects were
received PanOptix IOLs in both eyes
• Results: Subjects who received the PanOptix IOL achieved a mean visual acuity of 20/25 or better from +0.50
D to –2.50 D
Kohnen T, et al. Multicenter defocus curve evaluation of a novel trifocal presbyopia correcting intraocular lens: 6 months postoperative results. Free paper
presentation. ASCRS 2017 Los Angeles
9 | EMEA 2018 | Jan 2018
Short term visual outcomes of a new trifocal intraocular lens. Garcia–Perez JL, et al.
• Purpose: to report the short-term visual outcomes of PanOptix IOL
• Methods: 58 patients receiving bilateral implantation of the PanOptix IOL. 1 month follow up
- Three patients (5.1%) reported the need for
spectacle correction for certain activities.
All other patients (94.8%) reported never using spectacle correction.
García-Pérez et al. BMC Ophthalmology (2017) 17:72
10 | EMEA 2018 | Jan 2018
Visual and refractive outcomes following implantation of a new trifocal intraocular lens.
Lawless M, et al.
• Purpose: retrospectively assessment of the predictability, safety and efficacy of PanOptix IOL
following cataract or refractive lens exchange (RLE) surgery.
• Methods: 34 patients were bilaterally implanted with the PanOptix IOL. Follow-up from 4 to 9
weeks
• Results: Mean postoperative UDVA was 0.01 ± 0.10 LogMAR. All patients achieved an unaided
distance acuity of 20/40 or better postoperatively. No intraoperative complications were noted. Five
patients complained of moderate haloes in the early postoperative period
Lawless et al. Eye and Vision (2017) 4:10
12 | EMEA 2018 | Jan 2018
Trifocal intraocular lenses: a comparison of the visual performance and quality of vision
provided by two different lens designs. Gundersen GK, et al.
• Purpose: To compare PanOptix and FineVision trifocal IOL designs, evaluating longer-term refractive
outcomes, visual acuity (VA) at various distances, low contrast VA and quality of vision.
• Methods: 60 patients binocularly implanted (30 patients per group) were evaluated 6 months to 2 years
after surgery.
• Results:
- BCIVA & UIVA were significantly better for the
PanOptix lens at 60 cm (p<0.01).
- The binocular defocus curves differed −1.0 D
(FineVision better), −1.5 and −2.00 D (PanOptix better)
(figure)
Gundersen GK, et al. Clinical Ophthalmology 2017:11 1081–1087
PanOptix
FineVision
The preferred reading distance was
between 42 and 43 cm for both lenses, with
the VA at the preferred reading distance
slightly better with the PanOptix lens
13 | EMEA 2018 | Jan 2018
Visual performance after bilateral implantation of 2 new presbyopia-correcting intraocular
lenses: Trifocal versus extended range of vision. Monaco G, et al.
• Purpose: To compare the visual outcomes and quality of vision of PanOptix and Symfony IOLs
with those of a monofocal IOL (AcrySof SN60WF)
• Methods: 20 patients in each arm of the study (60 patients,120 eyes) completed the outcome
assessment at 4 months postoperatively
• Results:
- PanOptix had significantly better near VA
(0.02 ± 0.06 logMAR) than Symfony group
(0.07 ± 0.08 logMAR; p=0.05)
- The defocus curve showed PanOptix IOL
had better intermediate/near performance than
the Symfony lens and both multifocal IOLs
performed better than the monofocal IOL (figure)
Monaco G, et al. Cataract Refract Surg 2017; 43:737–747
Continue in the next slide...
Extended Range Of Vision
Trifocal
Monofocal
14 | EMEA 2018 | Jan 2018
Visual performance after bilateral implantation of 2 new presbyopia-correcting intraocular
lenses: Trifocal versus extended range of vision. Monaco G, et al.
• Results:
- Intragroup comparison of the total higher-order aberrations, PSF, MTF, and retinal straylight were not
statistically different.
- The Quality of Vision questionnaire results showed no differences in dysphotopsia between the multifocal
IOL groups; however, the results were significantly higher than in the monofocal IOL group (figure)
Monaco G, et al. Cataract Refract Surg 2017; 43:737–747
Extended Range Of Vision
Trifocal
Monofocal
15 | EMEA 2018 | Jan 2018
A comparative study of the visual outcomes between a new trifocal and an extended depth pf
focus intraocular lens. Ruiz-mesa R, et. al
• Purpose: To evaluate and compare visual outcomes and ocular optical performance of the
PanOptix and Symfony IOLs
• Methods: 34 patients were bilaterally implanted with the PanOptix IOL (20 patients) or with the
symfony IOL (14 patients)
Ruiz-Mesa R, et al. Eur J Ophthalmol 2017 (in press)
Continue in the next slide...
• Results:
- PanOptix showed significantly better near VA (0.04 ± 0.06
logMAR) than Symfony IOL (0.20 ± 0.07 logMAR; p<0.001)
- Similar preferred reading distances were found for both groups,
but PanOptix showed better VA at that distance (p<0.001):
PanOptix: 0.09 ± 0.08 logMAR at 37 cm
Symfony: 0.19 ± 0.08 logMAR at 38.9 cm
- The defocus curve showed significantly better outcomes for the
PanOptix IOL from -2.0 to -4.0 D (figure)
16 | EMEA 2018 | Jan 2018
Ruiz-Mesa R, et al. Eur J Ophthalmol 2017 (in press)
• Results:
- No significant differences were found for contrast sensitivity, halometry, or HOAs between the groups (figure)
A comparative study of the visual outcomes between a new trifocal and an extended depth pf
focus intraocular lens. Ruiz-mesa R, et. al
Pazienti con cataratta o presbiopia
motivazione a eliminare o ridurre l’uso degli occhiali
si no
mIOLs IOL monofocale
Motivati Motivati Motivati ma con
con aspettative ma con aspettative aspettative irrealistiche
realistiche molto elevate o con patologie oculari
Pazienti ideali Pazienti difficili
Compromesso
Aspettativa
Nuovo IOL TRIFOCALE: caratteristiche tecniche

More Related Content

What's hot

Comparing Extended-Depth-Of-Focus and Multifocal IOLs
Comparing Extended-Depth-Of-Focus and Multifocal IOLsComparing Extended-Depth-Of-Focus and Multifocal IOLs
Comparing Extended-Depth-Of-Focus and Multifocal IOLs
Dr. Anthony Roberts
 
Premier IOL choices-Technique & Decision Making
 Premier IOL choices-Technique & Decision Making Premier IOL choices-Technique & Decision Making
Premier IOL choices-Technique & Decision Making
presmedaustralia
 
Introduction of a new diffractive trifocal intraocular lens. Comparison with ...
Introduction of a new diffractive trifocal intraocular lens. Comparison with ...Introduction of a new diffractive trifocal intraocular lens. Comparison with ...
Introduction of a new diffractive trifocal intraocular lens. Comparison with ...
Breyer, Kaymak & Klabe Augenchirurgie
 
Accommodating IOLs
Accommodating IOLsAccommodating IOLs
Accommodating IOLs
Visionary Ophthamology
 
Visual acuity and patient satisfaction results with a new trifocal diffractiv...
Visual acuity and patient satisfaction results with a new trifocal diffractiv...Visual acuity and patient satisfaction results with a new trifocal diffractiv...
Visual acuity and patient satisfaction results with a new trifocal diffractiv...
presmedaustralia
 
Intra Oular Lenses
Intra Oular LensesIntra Oular Lenses
Intra Oular Lenses
slidenka
 
Accommodative and multifocal intraocular lenses
Accommodative and multifocal intraocular lensesAccommodative and multifocal intraocular lenses
Accommodative and multifocal intraocular lenses
Bijan Farpour
 
Intra ocular lens
Intra ocular lensIntra ocular lens
Intra ocular lens
Vishnu Narayanan
 
Phakic IOL
Phakic IOLPhakic IOL
Phakic IOL
Gauree Gattani
 
Types of Intraocular Lenses
Types of Intraocular LensesTypes of Intraocular Lenses
Types of Intraocular Lenses
Dr. Anthony Roberts
 
Laser Blended Vision for Presbyopia:
Laser Blended Vision for Presbyopia: Laser Blended Vision for Presbyopia:
Laser Blended Vision for Presbyopia:
London Vision Clinic
 
Multifocal IOL
Multifocal IOLMultifocal IOL
Multifocal IOL
Asad Zaman
 
Secondary Piggyback Iol Implantation For Correction Of Residual Refractive Er...
Secondary Piggyback Iol Implantation For Correction Of Residual Refractive Er...Secondary Piggyback Iol Implantation For Correction Of Residual Refractive Er...
Secondary Piggyback Iol Implantation For Correction Of Residual Refractive Er...
Dr. Jagannath Boramani
 
Mutifocal iols
Mutifocal iolsMutifocal iols
Mutifocal iols
sri kiran eye institue
 
Intraocular lens
Intraocular lensIntraocular lens
Intraocular lens
VASIUR RAHMAN
 
Vaishno medisales: AOE 2021
Vaishno medisales: AOE 2021Vaishno medisales: AOE 2021
Vaishno medisales: AOE 2021
Mero Eye
 
Vaishno medisales: AOE 2021
Vaishno medisales: AOE 2021Vaishno medisales: AOE 2021
Vaishno medisales: AOE 2021
Mero Eye
 
Co Management Made Easier IOL
Co Management Made Easier IOL Co Management Made Easier IOL
Co Management Made Easier IOL
Visionary Ophthamology
 
How currently achieve an EDoF lens
How currently achieve an EDoF lensHow currently achieve an EDoF lens
How currently achieve an EDoF lens
Sebastien Franssens
 
Premium oils intraoperative consideration
Premium oils intraoperative considerationPremium oils intraoperative consideration
Premium oils intraoperative consideration
Mehdi Khanlari
 

What's hot (20)

Comparing Extended-Depth-Of-Focus and Multifocal IOLs
Comparing Extended-Depth-Of-Focus and Multifocal IOLsComparing Extended-Depth-Of-Focus and Multifocal IOLs
Comparing Extended-Depth-Of-Focus and Multifocal IOLs
 
Premier IOL choices-Technique & Decision Making
 Premier IOL choices-Technique & Decision Making Premier IOL choices-Technique & Decision Making
Premier IOL choices-Technique & Decision Making
 
Introduction of a new diffractive trifocal intraocular lens. Comparison with ...
Introduction of a new diffractive trifocal intraocular lens. Comparison with ...Introduction of a new diffractive trifocal intraocular lens. Comparison with ...
Introduction of a new diffractive trifocal intraocular lens. Comparison with ...
 
Accommodating IOLs
Accommodating IOLsAccommodating IOLs
Accommodating IOLs
 
Visual acuity and patient satisfaction results with a new trifocal diffractiv...
Visual acuity and patient satisfaction results with a new trifocal diffractiv...Visual acuity and patient satisfaction results with a new trifocal diffractiv...
Visual acuity and patient satisfaction results with a new trifocal diffractiv...
 
Intra Oular Lenses
Intra Oular LensesIntra Oular Lenses
Intra Oular Lenses
 
Accommodative and multifocal intraocular lenses
Accommodative and multifocal intraocular lensesAccommodative and multifocal intraocular lenses
Accommodative and multifocal intraocular lenses
 
Intra ocular lens
Intra ocular lensIntra ocular lens
Intra ocular lens
 
Phakic IOL
Phakic IOLPhakic IOL
Phakic IOL
 
Types of Intraocular Lenses
Types of Intraocular LensesTypes of Intraocular Lenses
Types of Intraocular Lenses
 
Laser Blended Vision for Presbyopia:
Laser Blended Vision for Presbyopia: Laser Blended Vision for Presbyopia:
Laser Blended Vision for Presbyopia:
 
Multifocal IOL
Multifocal IOLMultifocal IOL
Multifocal IOL
 
Secondary Piggyback Iol Implantation For Correction Of Residual Refractive Er...
Secondary Piggyback Iol Implantation For Correction Of Residual Refractive Er...Secondary Piggyback Iol Implantation For Correction Of Residual Refractive Er...
Secondary Piggyback Iol Implantation For Correction Of Residual Refractive Er...
 
Mutifocal iols
Mutifocal iolsMutifocal iols
Mutifocal iols
 
Intraocular lens
Intraocular lensIntraocular lens
Intraocular lens
 
Vaishno medisales: AOE 2021
Vaishno medisales: AOE 2021Vaishno medisales: AOE 2021
Vaishno medisales: AOE 2021
 
Vaishno medisales: AOE 2021
Vaishno medisales: AOE 2021Vaishno medisales: AOE 2021
Vaishno medisales: AOE 2021
 
Co Management Made Easier IOL
Co Management Made Easier IOL Co Management Made Easier IOL
Co Management Made Easier IOL
 
How currently achieve an EDoF lens
How currently achieve an EDoF lensHow currently achieve an EDoF lens
How currently achieve an EDoF lens
 
Premium oils intraoperative consideration
Premium oils intraoperative considerationPremium oils intraoperative consideration
Premium oils intraoperative consideration
 

Similar to Nuovo IOL TRIFOCALE: caratteristiche tecniche

Panoptix vs finevision ESCRS 2017
Panoptix vs finevision ESCRS 2017Panoptix vs finevision ESCRS 2017
Panoptix vs finevision ESCRS 2017
Clínica Rementería
 
Journal Presentation.pptx
Journal Presentation.pptxJournal Presentation.pptx
Journal Presentation.pptx
Dr.Maliha Nawar
 
09 long term-follow-up
09 long term-follow-up09 long term-follow-up
09 long term-follow-up
Ferrara Ophthalmics
 
A Comparison of The Lateral Tarsal Strip with Everting Sutures and The Quic...
A Comparison  of  The Lateral Tarsal Strip with Everting Sutures and The Quic...A Comparison  of  The Lateral Tarsal Strip with Everting Sutures and The Quic...
A Comparison of The Lateral Tarsal Strip with Everting Sutures and The Quic...
Meironi Waimir
 
14 10 years follow-up
14 10 years follow-up 14 10 years follow-up
14 10 years follow-up
Ferrara Ophthalmics
 
Resultados preliminares do implante de um novo anel associado ao PRK para pre...
Resultados preliminares do implante de um novo anel associado ao PRK para pre...Resultados preliminares do implante de um novo anel associado ao PRK para pre...
Resultados preliminares do implante de um novo anel associado ao PRK para pre...
Ferrara Ophthalmics
 
Comparative Study of Visual Outcome between Femtosecond Lasik with Excimer La...
Comparative Study of Visual Outcome between Femtosecond Lasik with Excimer La...Comparative Study of Visual Outcome between Femtosecond Lasik with Excimer La...
Comparative Study of Visual Outcome between Femtosecond Lasik with Excimer La...
iosrjce
 
12 refractive tomographic biomechanical outcomes
12 refractive tomographic biomechanical outcomes12 refractive tomographic biomechanical outcomes
12 refractive tomographic biomechanical outcomes
Ferrara Ophthalmics
 
13 reoperation
13 reoperation13 reoperation
13 reoperation
Ferrara Ophthalmics
 
Journal club on Magnification loupes
Journal club on Magnification loupesJournal club on Magnification loupes
Journal club on Magnification loupes
Dr Abhilasha
 
European_Society_of_Ophthalmology_Europe.pdf
European_Society_of_Ophthalmology_Europe.pdfEuropean_Society_of_Ophthalmology_Europe.pdf
European_Society_of_Ophthalmology_Europe.pdf
gabrielladesalvo
 
Alcon hayderabad premium slide show
Alcon hayderabad premium slide showAlcon hayderabad premium slide show
Dr. Vedat Kaya (MAKALE)
Dr. Vedat Kaya (MAKALE)Dr. Vedat Kaya (MAKALE)
Dr. Vedat Kaya (MAKALE)
Lasermed Tic
 
Erika Eskina ASCRS 2015: One-Year Outcome of Presbyopia Correction in Myopic ...
Erika Eskina ASCRS 2015: One-Year Outcome of Presbyopia Correction in Myopic ...Erika Eskina ASCRS 2015: One-Year Outcome of Presbyopia Correction in Myopic ...
Erika Eskina ASCRS 2015: One-Year Outcome of Presbyopia Correction in Myopic ...
Сфера — клиника профессора Эскиной Э.Н.
 
Kamra
KamraKamra
Contact lenses
Contact lensesContact lenses
Contact lenses
arjun sapkota
 
Intacs, Corneal inserts for treatment of keratoconus and ectasia
Intacs, Corneal inserts for treatment of keratoconus and ectasiaIntacs, Corneal inserts for treatment of keratoconus and ectasia
Intacs, Corneal inserts for treatment of keratoconus and ectasia
Michael Duplessie
 
Ferrara ICRS in Mild Keratoconus
Ferrara ICRS in Mild KeratoconusFerrara ICRS in Mild Keratoconus
Ferrara ICRS in Mild Keratoconus
Ferrara Ophthalmics
 
Premium IOL revolution.pptx
Premium IOL revolution.pptxPremium IOL revolution.pptx
Premium IOL revolution.pptx
ssuser184ca41
 
31 lr high_l_feb_2012_staar_public[1]
31 lr high_l_feb_2012_staar_public[1]31 lr high_l_feb_2012_staar_public[1]
31 lr high_l_feb_2012_staar_public[1]
Lasermed Tic
 

Similar to Nuovo IOL TRIFOCALE: caratteristiche tecniche (20)

Panoptix vs finevision ESCRS 2017
Panoptix vs finevision ESCRS 2017Panoptix vs finevision ESCRS 2017
Panoptix vs finevision ESCRS 2017
 
Journal Presentation.pptx
Journal Presentation.pptxJournal Presentation.pptx
Journal Presentation.pptx
 
09 long term-follow-up
09 long term-follow-up09 long term-follow-up
09 long term-follow-up
 
A Comparison of The Lateral Tarsal Strip with Everting Sutures and The Quic...
A Comparison  of  The Lateral Tarsal Strip with Everting Sutures and The Quic...A Comparison  of  The Lateral Tarsal Strip with Everting Sutures and The Quic...
A Comparison of The Lateral Tarsal Strip with Everting Sutures and The Quic...
 
14 10 years follow-up
14 10 years follow-up 14 10 years follow-up
14 10 years follow-up
 
Resultados preliminares do implante de um novo anel associado ao PRK para pre...
Resultados preliminares do implante de um novo anel associado ao PRK para pre...Resultados preliminares do implante de um novo anel associado ao PRK para pre...
Resultados preliminares do implante de um novo anel associado ao PRK para pre...
 
Comparative Study of Visual Outcome between Femtosecond Lasik with Excimer La...
Comparative Study of Visual Outcome between Femtosecond Lasik with Excimer La...Comparative Study of Visual Outcome between Femtosecond Lasik with Excimer La...
Comparative Study of Visual Outcome between Femtosecond Lasik with Excimer La...
 
12 refractive tomographic biomechanical outcomes
12 refractive tomographic biomechanical outcomes12 refractive tomographic biomechanical outcomes
12 refractive tomographic biomechanical outcomes
 
13 reoperation
13 reoperation13 reoperation
13 reoperation
 
Journal club on Magnification loupes
Journal club on Magnification loupesJournal club on Magnification loupes
Journal club on Magnification loupes
 
European_Society_of_Ophthalmology_Europe.pdf
European_Society_of_Ophthalmology_Europe.pdfEuropean_Society_of_Ophthalmology_Europe.pdf
European_Society_of_Ophthalmology_Europe.pdf
 
Alcon hayderabad premium slide show
Alcon hayderabad premium slide showAlcon hayderabad premium slide show
Alcon hayderabad premium slide show
 
Dr. Vedat Kaya (MAKALE)
Dr. Vedat Kaya (MAKALE)Dr. Vedat Kaya (MAKALE)
Dr. Vedat Kaya (MAKALE)
 
Erika Eskina ASCRS 2015: One-Year Outcome of Presbyopia Correction in Myopic ...
Erika Eskina ASCRS 2015: One-Year Outcome of Presbyopia Correction in Myopic ...Erika Eskina ASCRS 2015: One-Year Outcome of Presbyopia Correction in Myopic ...
Erika Eskina ASCRS 2015: One-Year Outcome of Presbyopia Correction in Myopic ...
 
Kamra
KamraKamra
Kamra
 
Contact lenses
Contact lensesContact lenses
Contact lenses
 
Intacs, Corneal inserts for treatment of keratoconus and ectasia
Intacs, Corneal inserts for treatment of keratoconus and ectasiaIntacs, Corneal inserts for treatment of keratoconus and ectasia
Intacs, Corneal inserts for treatment of keratoconus and ectasia
 
Ferrara ICRS in Mild Keratoconus
Ferrara ICRS in Mild KeratoconusFerrara ICRS in Mild Keratoconus
Ferrara ICRS in Mild Keratoconus
 
Premium IOL revolution.pptx
Premium IOL revolution.pptxPremium IOL revolution.pptx
Premium IOL revolution.pptx
 
31 lr high_l_feb_2012_staar_public[1]
31 lr high_l_feb_2012_staar_public[1]31 lr high_l_feb_2012_staar_public[1]
31 lr high_l_feb_2012_staar_public[1]
 

More from ASMaD

Presa in carico del paziente con LMC e gestione della terapia a medio e lungo...
Presa in carico del paziente con LMC e gestione della terapia a medio e lungo...Presa in carico del paziente con LMC e gestione della terapia a medio e lungo...
Presa in carico del paziente con LMC e gestione della terapia a medio e lungo...
ASMaD
 
Presa in carico del paziente con LMC e gestione della terapia a medio e lungo...
Presa in carico del paziente con LMC e gestione della terapia a medio e lungo...Presa in carico del paziente con LMC e gestione della terapia a medio e lungo...
Presa in carico del paziente con LMC e gestione della terapia a medio e lungo...
ASMaD
 
Presa in carico del paziente con LMC e gestione della terapia a medio e lungo...
Presa in carico del paziente con LMC e gestione della terapia a medio e lungo...Presa in carico del paziente con LMC e gestione della terapia a medio e lungo...
Presa in carico del paziente con LMC e gestione della terapia a medio e lungo...
ASMaD
 
Presa in carico del paziente con LMC e gestione della terapia a medio e lungo...
Presa in carico del paziente con LMC e gestione della terapia a medio e lungo...Presa in carico del paziente con LMC e gestione della terapia a medio e lungo...
Presa in carico del paziente con LMC e gestione della terapia a medio e lungo...
ASMaD
 
Presa in carico del paziente con LMC e gestione della terapia a medio e lungo...
Presa in carico del paziente con LMC e gestione della terapia a medio e lungo...Presa in carico del paziente con LMC e gestione della terapia a medio e lungo...
Presa in carico del paziente con LMC e gestione della terapia a medio e lungo...
ASMaD
 
Presa in carico del paziente con LMC e gestione della terapia a medio e lungo...
Presa in carico del paziente con LMC e gestione della terapia a medio e lungo...Presa in carico del paziente con LMC e gestione della terapia a medio e lungo...
Presa in carico del paziente con LMC e gestione della terapia a medio e lungo...
ASMaD
 
I meccanismi del danno gastrico e la patologia H. Pylori correlata
I meccanismi del danno gastrico e la patologia H. Pylori correlataI meccanismi del danno gastrico e la patologia H. Pylori correlata
I meccanismi del danno gastrico e la patologia H. Pylori correlata
ASMaD
 
Helicobacter Pylori: editoriale
Helicobacter Pylori: editorialeHelicobacter Pylori: editoriale
Helicobacter Pylori: editoriale
ASMaD
 
Ph impedenziometria nella MRGE: quando, come e perchè
Ph impedenziometria nella MRGE: quando, come e perchèPh impedenziometria nella MRGE: quando, come e perchè
Ph impedenziometria nella MRGE: quando, come e perchè
ASMaD
 
Endoscopia nella MRGE: quando, come e perchè
Endoscopia nella MRGE: quando, come e perchèEndoscopia nella MRGE: quando, come e perchè
Endoscopia nella MRGE: quando, come e perchè
ASMaD
 
Editoriale: malattia da reflusso
Editoriale: malattia da reflussoEditoriale: malattia da reflusso
Editoriale: malattia da reflusso
ASMaD
 
Cambiamenti di popolazione e flussi migratori: cambiano anche le malattie met...
Cambiamenti di popolazione e flussi migratori: cambiano anche le malattie met...Cambiamenti di popolazione e flussi migratori: cambiano anche le malattie met...
Cambiamenti di popolazione e flussi migratori: cambiano anche le malattie met...
ASMaD
 
Tiroide: chi decide quale intervento e per chi?
Tiroide: chi decide quale intervento e per chi?Tiroide: chi decide quale intervento e per chi?
Tiroide: chi decide quale intervento e per chi?
ASMaD
 
Tiroide: Integrazione tra elementi nutriacetici e farmacologia: utile o inutile?
Tiroide: Integrazione tra elementi nutriacetici e farmacologia: utile o inutile?Tiroide: Integrazione tra elementi nutriacetici e farmacologia: utile o inutile?
Tiroide: Integrazione tra elementi nutriacetici e farmacologia: utile o inutile?
ASMaD
 
L'ecografia tiroidea: strumento cruciale nella gestione clinica?
L'ecografia tiroidea: strumento cruciale nella gestione clinica?L'ecografia tiroidea: strumento cruciale nella gestione clinica?
L'ecografia tiroidea: strumento cruciale nella gestione clinica?
ASMaD
 
Nodulo tiroideo un ago aspirato per uno non fa male a nessuno?
Nodulo tiroideo un ago aspirato per uno non fa male a nessuno?Nodulo tiroideo un ago aspirato per uno non fa male a nessuno?
Nodulo tiroideo un ago aspirato per uno non fa male a nessuno?
ASMaD
 
Ipotiroidismo subclinico: conoscerlo per condividerlo. Quando la terapia? Qua...
Ipotiroidismo subclinico: conoscerlo per condividerlo. Quando la terapia? Qua...Ipotiroidismo subclinico: conoscerlo per condividerlo. Quando la terapia? Qua...
Ipotiroidismo subclinico: conoscerlo per condividerlo. Quando la terapia? Qua...
ASMaD
 
Il chirurgo e la tiroide oggi: un rapporto in crisi?
Il chirurgo e la tiroide oggi: un rapporto in crisi?Il chirurgo e la tiroide oggi: un rapporto in crisi?
Il chirurgo e la tiroide oggi: un rapporto in crisi?
ASMaD
 
Il chirurgo e la tiroide oggi un rapporto in crisi?
Il chirurgo e la tiroide oggi un rapporto in crisi?Il chirurgo e la tiroide oggi un rapporto in crisi?
Il chirurgo e la tiroide oggi un rapporto in crisi?
ASMaD
 
Follw up della neoplasia tiroidea gregorio reda
Follw up della neoplasia tiroidea gregorio redaFollw up della neoplasia tiroidea gregorio reda
Follw up della neoplasia tiroidea gregorio reda
ASMaD
 

More from ASMaD (20)

Presa in carico del paziente con LMC e gestione della terapia a medio e lungo...
Presa in carico del paziente con LMC e gestione della terapia a medio e lungo...Presa in carico del paziente con LMC e gestione della terapia a medio e lungo...
Presa in carico del paziente con LMC e gestione della terapia a medio e lungo...
 
Presa in carico del paziente con LMC e gestione della terapia a medio e lungo...
Presa in carico del paziente con LMC e gestione della terapia a medio e lungo...Presa in carico del paziente con LMC e gestione della terapia a medio e lungo...
Presa in carico del paziente con LMC e gestione della terapia a medio e lungo...
 
Presa in carico del paziente con LMC e gestione della terapia a medio e lungo...
Presa in carico del paziente con LMC e gestione della terapia a medio e lungo...Presa in carico del paziente con LMC e gestione della terapia a medio e lungo...
Presa in carico del paziente con LMC e gestione della terapia a medio e lungo...
 
Presa in carico del paziente con LMC e gestione della terapia a medio e lungo...
Presa in carico del paziente con LMC e gestione della terapia a medio e lungo...Presa in carico del paziente con LMC e gestione della terapia a medio e lungo...
Presa in carico del paziente con LMC e gestione della terapia a medio e lungo...
 
Presa in carico del paziente con LMC e gestione della terapia a medio e lungo...
Presa in carico del paziente con LMC e gestione della terapia a medio e lungo...Presa in carico del paziente con LMC e gestione della terapia a medio e lungo...
Presa in carico del paziente con LMC e gestione della terapia a medio e lungo...
 
Presa in carico del paziente con LMC e gestione della terapia a medio e lungo...
Presa in carico del paziente con LMC e gestione della terapia a medio e lungo...Presa in carico del paziente con LMC e gestione della terapia a medio e lungo...
Presa in carico del paziente con LMC e gestione della terapia a medio e lungo...
 
I meccanismi del danno gastrico e la patologia H. Pylori correlata
I meccanismi del danno gastrico e la patologia H. Pylori correlataI meccanismi del danno gastrico e la patologia H. Pylori correlata
I meccanismi del danno gastrico e la patologia H. Pylori correlata
 
Helicobacter Pylori: editoriale
Helicobacter Pylori: editorialeHelicobacter Pylori: editoriale
Helicobacter Pylori: editoriale
 
Ph impedenziometria nella MRGE: quando, come e perchè
Ph impedenziometria nella MRGE: quando, come e perchèPh impedenziometria nella MRGE: quando, come e perchè
Ph impedenziometria nella MRGE: quando, come e perchè
 
Endoscopia nella MRGE: quando, come e perchè
Endoscopia nella MRGE: quando, come e perchèEndoscopia nella MRGE: quando, come e perchè
Endoscopia nella MRGE: quando, come e perchè
 
Editoriale: malattia da reflusso
Editoriale: malattia da reflussoEditoriale: malattia da reflusso
Editoriale: malattia da reflusso
 
Cambiamenti di popolazione e flussi migratori: cambiano anche le malattie met...
Cambiamenti di popolazione e flussi migratori: cambiano anche le malattie met...Cambiamenti di popolazione e flussi migratori: cambiano anche le malattie met...
Cambiamenti di popolazione e flussi migratori: cambiano anche le malattie met...
 
Tiroide: chi decide quale intervento e per chi?
Tiroide: chi decide quale intervento e per chi?Tiroide: chi decide quale intervento e per chi?
Tiroide: chi decide quale intervento e per chi?
 
Tiroide: Integrazione tra elementi nutriacetici e farmacologia: utile o inutile?
Tiroide: Integrazione tra elementi nutriacetici e farmacologia: utile o inutile?Tiroide: Integrazione tra elementi nutriacetici e farmacologia: utile o inutile?
Tiroide: Integrazione tra elementi nutriacetici e farmacologia: utile o inutile?
 
L'ecografia tiroidea: strumento cruciale nella gestione clinica?
L'ecografia tiroidea: strumento cruciale nella gestione clinica?L'ecografia tiroidea: strumento cruciale nella gestione clinica?
L'ecografia tiroidea: strumento cruciale nella gestione clinica?
 
Nodulo tiroideo un ago aspirato per uno non fa male a nessuno?
Nodulo tiroideo un ago aspirato per uno non fa male a nessuno?Nodulo tiroideo un ago aspirato per uno non fa male a nessuno?
Nodulo tiroideo un ago aspirato per uno non fa male a nessuno?
 
Ipotiroidismo subclinico: conoscerlo per condividerlo. Quando la terapia? Qua...
Ipotiroidismo subclinico: conoscerlo per condividerlo. Quando la terapia? Qua...Ipotiroidismo subclinico: conoscerlo per condividerlo. Quando la terapia? Qua...
Ipotiroidismo subclinico: conoscerlo per condividerlo. Quando la terapia? Qua...
 
Il chirurgo e la tiroide oggi: un rapporto in crisi?
Il chirurgo e la tiroide oggi: un rapporto in crisi?Il chirurgo e la tiroide oggi: un rapporto in crisi?
Il chirurgo e la tiroide oggi: un rapporto in crisi?
 
Il chirurgo e la tiroide oggi un rapporto in crisi?
Il chirurgo e la tiroide oggi un rapporto in crisi?Il chirurgo e la tiroide oggi un rapporto in crisi?
Il chirurgo e la tiroide oggi un rapporto in crisi?
 
Follw up della neoplasia tiroidea gregorio reda
Follw up della neoplasia tiroidea gregorio redaFollw up della neoplasia tiroidea gregorio reda
Follw up della neoplasia tiroidea gregorio reda
 

Recently uploaded

Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
Dr. Nikhilkumar Sakle
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathologypathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
ZayedKhan38
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
NX Healthcare
 
How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.
Gokuldas Hospital
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
AksshayaRajanbabu
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHYMERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
DRPREETHIJAMESP
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptxCLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
Government Dental College & Hospital Srinagar
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
LEFLOT Jean-Louis
 

Recently uploaded (20)

Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathologypathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
 
How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHYMERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptxCLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
 

Nuovo IOL TRIFOCALE: caratteristiche tecniche

  • 1. Nuova IOL TRIFOCALE: caratteristiche tecniche Francesca Pietrolucci UOC Oftalmologia AUSL/RI
  • 2. Diffractive Trifocal IOLs the newest option to compensate presbyopia • Diffractive trifocal pattern • No clinically significant deterioration of visual quality • Different models avoidable
  • 3. First Generation • PhysIOL • FineVision Micro F – Launched in 2010 • FineVision Toric – Launched in 2014 • Carl Zeiss Meditec • AT LISA tri 839MP – Launched in 2012 • AT LISA tri Toric 939MP – Launched in 2013 Second Generation • Alcon • AcrySof PanOptix IOL – Launched in 2015 • AcrySof PanOptix Toric IOL – Launched in 2017 Evolution of Trifocal IOL’s Design
  • 4. Traditional Trifocal: • 2 step heights = 2 add powers • Intermediate focal point of 80 cm to maintain usable near vision Quadrifocal Technology: • 3 step heights = 3 add powers • Energy evenly distributed among Distance, 120 cm, 60 cm and 40 cm ENLIGHTEN™ Optical Technology: • 2 step heights = 2 add powers • Redirects light from the 1st step height (120 cm) to Distance • Light splits three ways: Distance, 60 cm, and 40 cm Energy Distan 0th 1/40 1/Focal 2nd distance Energy 1/120 1/40 1/Focal 3rd Distance 0th distance Energy 1/40 1/Focal 3rd Dist 0 distance
  • 5.
  • 6. 6 | EMEA 2018 | Jan 2018 In-vitro, bench characterization via MTF PanOptix IOL vs. ReSTOR +3.0 D IOL Lee et al Clin Ophthalmol. 2016:10 1031–1038 50 lp/mm100 lp/mm
  • 7.
  • 8. 8 | EMEA 2018 | Jan 2018 Multicenter defocus curve evaluation of a novel trifocal presbyopia correcting intraocular lens: 6 months postoperative results. Kohnen T, et al • Purpose: To determine the binocular defocus curve of the AcrySof IQ PanOptix IOL, at 6 months post- implantation • Methods: Prospective, single-arm, non-randomized and multicenter study. A total of 143 subjects were received PanOptix IOLs in both eyes • Results: Subjects who received the PanOptix IOL achieved a mean visual acuity of 20/25 or better from +0.50 D to –2.50 D Kohnen T, et al. Multicenter defocus curve evaluation of a novel trifocal presbyopia correcting intraocular lens: 6 months postoperative results. Free paper presentation. ASCRS 2017 Los Angeles
  • 9. 9 | EMEA 2018 | Jan 2018 Short term visual outcomes of a new trifocal intraocular lens. Garcia–Perez JL, et al. • Purpose: to report the short-term visual outcomes of PanOptix IOL • Methods: 58 patients receiving bilateral implantation of the PanOptix IOL. 1 month follow up - Three patients (5.1%) reported the need for spectacle correction for certain activities. All other patients (94.8%) reported never using spectacle correction. García-Pérez et al. BMC Ophthalmology (2017) 17:72
  • 10. 10 | EMEA 2018 | Jan 2018 Visual and refractive outcomes following implantation of a new trifocal intraocular lens. Lawless M, et al. • Purpose: retrospectively assessment of the predictability, safety and efficacy of PanOptix IOL following cataract or refractive lens exchange (RLE) surgery. • Methods: 34 patients were bilaterally implanted with the PanOptix IOL. Follow-up from 4 to 9 weeks • Results: Mean postoperative UDVA was 0.01 ± 0.10 LogMAR. All patients achieved an unaided distance acuity of 20/40 or better postoperatively. No intraoperative complications were noted. Five patients complained of moderate haloes in the early postoperative period Lawless et al. Eye and Vision (2017) 4:10
  • 11. 12 | EMEA 2018 | Jan 2018 Trifocal intraocular lenses: a comparison of the visual performance and quality of vision provided by two different lens designs. Gundersen GK, et al. • Purpose: To compare PanOptix and FineVision trifocal IOL designs, evaluating longer-term refractive outcomes, visual acuity (VA) at various distances, low contrast VA and quality of vision. • Methods: 60 patients binocularly implanted (30 patients per group) were evaluated 6 months to 2 years after surgery. • Results: - BCIVA & UIVA were significantly better for the PanOptix lens at 60 cm (p<0.01). - The binocular defocus curves differed −1.0 D (FineVision better), −1.5 and −2.00 D (PanOptix better) (figure) Gundersen GK, et al. Clinical Ophthalmology 2017:11 1081–1087 PanOptix FineVision The preferred reading distance was between 42 and 43 cm for both lenses, with the VA at the preferred reading distance slightly better with the PanOptix lens
  • 12. 13 | EMEA 2018 | Jan 2018 Visual performance after bilateral implantation of 2 new presbyopia-correcting intraocular lenses: Trifocal versus extended range of vision. Monaco G, et al. • Purpose: To compare the visual outcomes and quality of vision of PanOptix and Symfony IOLs with those of a monofocal IOL (AcrySof SN60WF) • Methods: 20 patients in each arm of the study (60 patients,120 eyes) completed the outcome assessment at 4 months postoperatively • Results: - PanOptix had significantly better near VA (0.02 ± 0.06 logMAR) than Symfony group (0.07 ± 0.08 logMAR; p=0.05) - The defocus curve showed PanOptix IOL had better intermediate/near performance than the Symfony lens and both multifocal IOLs performed better than the monofocal IOL (figure) Monaco G, et al. Cataract Refract Surg 2017; 43:737–747 Continue in the next slide... Extended Range Of Vision Trifocal Monofocal
  • 13. 14 | EMEA 2018 | Jan 2018 Visual performance after bilateral implantation of 2 new presbyopia-correcting intraocular lenses: Trifocal versus extended range of vision. Monaco G, et al. • Results: - Intragroup comparison of the total higher-order aberrations, PSF, MTF, and retinal straylight were not statistically different. - The Quality of Vision questionnaire results showed no differences in dysphotopsia between the multifocal IOL groups; however, the results were significantly higher than in the monofocal IOL group (figure) Monaco G, et al. Cataract Refract Surg 2017; 43:737–747 Extended Range Of Vision Trifocal Monofocal
  • 14. 15 | EMEA 2018 | Jan 2018 A comparative study of the visual outcomes between a new trifocal and an extended depth pf focus intraocular lens. Ruiz-mesa R, et. al • Purpose: To evaluate and compare visual outcomes and ocular optical performance of the PanOptix and Symfony IOLs • Methods: 34 patients were bilaterally implanted with the PanOptix IOL (20 patients) or with the symfony IOL (14 patients) Ruiz-Mesa R, et al. Eur J Ophthalmol 2017 (in press) Continue in the next slide... • Results: - PanOptix showed significantly better near VA (0.04 ± 0.06 logMAR) than Symfony IOL (0.20 ± 0.07 logMAR; p<0.001) - Similar preferred reading distances were found for both groups, but PanOptix showed better VA at that distance (p<0.001): PanOptix: 0.09 ± 0.08 logMAR at 37 cm Symfony: 0.19 ± 0.08 logMAR at 38.9 cm - The defocus curve showed significantly better outcomes for the PanOptix IOL from -2.0 to -4.0 D (figure)
  • 15. 16 | EMEA 2018 | Jan 2018 Ruiz-Mesa R, et al. Eur J Ophthalmol 2017 (in press) • Results: - No significant differences were found for contrast sensitivity, halometry, or HOAs between the groups (figure) A comparative study of the visual outcomes between a new trifocal and an extended depth pf focus intraocular lens. Ruiz-mesa R, et. al
  • 16. Pazienti con cataratta o presbiopia motivazione a eliminare o ridurre l’uso degli occhiali si no mIOLs IOL monofocale Motivati Motivati Motivati ma con con aspettative ma con aspettative aspettative irrealistiche realistiche molto elevate o con patologie oculari Pazienti ideali Pazienti difficili Compromesso Aspettativa